Multivariate cox analysis indicated both PD-L1 (HR = 0.231, P = 0.009) and ESCC-PS (P < 0.001) remained a significant prognostic indicator indicating the independent prognostic factors for ESCC patients receiving immunotherapy. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.